208 related articles for article (PubMed ID: 22728436)
1. A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.
Flentie K; Kocher B; Gammon ST; Novack DV; McKinney JS; Piwnica-Worms D
Cancer Discov; 2012 Jul; 2(7):624-37. PubMed ID: 22728436
[TBL] [Abstract][Full Text] [Related]
2. Bugging tumors.
Hoffman RM
Cancer Discov; 2012 Jul; 2(7):588-90. PubMed ID: 22787089
[TBL] [Abstract][Full Text] [Related]
3. Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella.
Mengesha A; Dubois L; Lambin P; Landuyt W; Chiu RK; Wouters BG; Theys J
Cancer Biol Ther; 2006 Sep; 5(9):1120-8. PubMed ID: 16855381
[TBL] [Abstract][Full Text] [Related]
4. Salmonella promoters preferentially activated inside tumors.
Arrach N; Zhao M; Porwollik S; Hoffman RM; McClelland M
Cancer Res; 2008 Jun; 68(12):4827-32. PubMed ID: 18559530
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents.
Hong H; Lim D; Kim GJ; Park SH; Sik Kim H; Hong Y; Choy HE; Min JJ
Cell Cycle; 2014; 13(19):3112-20. PubMed ID: 25486570
[TBL] [Abstract][Full Text] [Related]
6. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
7. High-level transgene expression mediated by the piggyBac transposon enhances transgenic therapeutic effects in cervical cancer xenografts.
Kang Y; Yu W; Sun Q; Zhang X; Jiang W; Wu C; Chen C; Gu J; Zheng Y; Xu C
Oncol Rep; 2010 Oct; 24(4):897-907. PubMed ID: 20811669
[TBL] [Abstract][Full Text] [Related]
8. Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
Chen J; Wei D; Zhuang H; Qiao Y; Tang B; Zhang X; Wei J; Fang S; Chen G; Du P; Huang X; Jiang W; Hu Q; Hua ZC
Mol Cell Proteomics; 2011 Jun; 10(6):M111.009399. PubMed ID: 21474796
[TBL] [Abstract][Full Text] [Related]
9. In vivo monitoring of antiangiogenic therapy by magnetic resonance and bioluminescence imaging in an M21 tumor model through activation of an hsp70 promoter-luciferase reporter construct.
Hundt W; Steinbach S; O'Connell-Rodwell CE; Mayer D; Burbelko M; Guccione S
Contrast Media Mol Imaging; 2012; 7(5):450-9. PubMed ID: 22821879
[TBL] [Abstract][Full Text] [Related]
10. Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.
Jiang SN; Park SH; Lee HJ; Zheng JH; Kim HS; Bom HS; Hong Y; Szardenings M; Shin MG; Kim SC; Ntziachristos V; Choy HE; Min JJ
Mol Ther; 2013 Nov; 21(11):1985-95. PubMed ID: 23922014
[TBL] [Abstract][Full Text] [Related]
11. Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon.
Geurts AM; Wilber A; Carlson CM; Lobitz PD; Clark KJ; Hackett PB; McIvor RS; Largaespada DA
BMC Biotechnol; 2006 Jun; 6():30. PubMed ID: 16800892
[TBL] [Abstract][Full Text] [Related]
12. Expression of a humanized viral 2A-mediated lux operon efficiently generates autonomous bioluminescence in human cells.
Xu T; Ripp S; Sayler GS; Close DM
PLoS One; 2014; 9(5):e96347. PubMed ID: 24788811
[TBL] [Abstract][Full Text] [Related]
13. Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design.
Mosaad EO; Futrega K; Seim I; Gloss B; Chambers KF; Clements JA; Doran MR
Sci Rep; 2019 Aug; 9(1):11334. PubMed ID: 31383876
[TBL] [Abstract][Full Text] [Related]
14. The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.
Hsieh YJ; Chen FD; Ke CC; Wang HE; Huang CJ; Hou MF; Lin KP; Gelovani JG; Liu RS
Mol Imaging Biol; 2012 Aug; 14(4):452-61. PubMed ID: 21796480
[TBL] [Abstract][Full Text] [Related]
15. Visualization of Anticancer Salmonella typhimurium Engineered for Remote Control of Therapeutic Proteins.
Nguyen VH; Min JJ
Methods Mol Biol; 2016; 1409():135-42. PubMed ID: 26846808
[TBL] [Abstract][Full Text] [Related]
16. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery.
Navarro G; Maiwald G; Haase R; Rogach AL; Wagner E; de Ilarduya CT; Ogris M
J Control Release; 2010 Aug; 146(1):99-105. PubMed ID: 20438778
[TBL] [Abstract][Full Text] [Related]
17. Tn5/7-lux: a versatile tool for the identification and capture of promoters in gram-negative bacteria.
Bruckbauer ST; Kvitko BH; Karkhoff-Schweizer RR; Schweizer HP
BMC Microbiol; 2015 Feb; 15(1):17. PubMed ID: 25648327
[TBL] [Abstract][Full Text] [Related]
18. Bacterial systems for gene delivery to systemic tumors.
Cummins J; Cronin M; van Pijkeren JP; Gahan CG; Tangney M
Methods Mol Biol; 2014; 1141():201-9. PubMed ID: 24567141
[TBL] [Abstract][Full Text] [Related]
19. Suppression of colorectal tumor growth by regulated survivin targeting.
Li B; Fan J; Liu X; Qi R; Bo L; Gu J; Qian C; Liu X
J Mol Med (Berl); 2006 Dec; 84(12):1077-86. PubMed ID: 17077982
[TBL] [Abstract][Full Text] [Related]
20. Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
Hine CM; Seluanov A; Gorbunova V
Mol Ther; 2012 Feb; 20(2):347-55. PubMed ID: 22008909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
